DINUTUXIMAB for Neuroblastoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 102 adverse event reports in the FDA FAERS database where DINUTUXIMAB was used for Neuroblastoma recurrent.
Most Reported Side Effects for DINUTUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 144 | 21.3% | 37 | 59 |
| Off label use | 95 | 14.1% | 17 | 30 |
| Neuroblastoma recurrent | 76 | 11.2% | 49 | 11 |
| Pain | 74 | 11.0% | 5 | 28 |
| Abdominal pain | 60 | 8.9% | 17 | 17 |
| Hypotension | 55 | 8.1% | 11 | 35 |
| Neuroblastoma | 49 | 7.3% | 30 | 5 |
| Anaemia | 47 | 7.0% | 24 | 8 |
| Aspartate aminotransferase increased | 46 | 6.8% | 11 | 11 |
| Alanine aminotransferase increased | 43 | 6.4% | 9 | 12 |
| Hypoxia | 42 | 6.2% | 5 | 17 |
| Vomiting | 42 | 6.2% | 5 | 15 |
| Hypoalbuminaemia | 41 | 6.1% | 10 | 11 |
| Diarrhoea | 40 | 5.9% | 7 | 23 |
| Pain in extremity | 40 | 5.9% | 10 | 19 |
Other Indications for DINUTUXIMAB
Neuroblastoma (354)
Product used for unknown indication (99)
Small cell lung cancer (37)
Metastases to bone (23)
Chemotherapy (16)
Metastases to liver (16)
Ganglioneuroblastoma (7)
Other Drugs Used for Neuroblastoma recurrent
TEMOZOLOMIDE (84)
CYCLOPHOSPHAMIDE (77)
IRINOTECAN (74)
TOPOTECAN (56)
ETOPOSIDE (54)
CARBOPLATIN (39)
NAXITAMAB-GQGK (38)
IFOSFAMIDE (21)
LORLATINIB (21)
RITUXIMAB (21)